FIGURE 4.
Frequency of the main clinical manifestations related to Still’s disease at the start of canakinumab and at the following time-points. MAS, macrophage activation syndrome.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.